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Abstract
Purpose: Intensity modulated radiotherapy (IMRT) for cervical esophageal cancer is challenging. Although IMRT techniques
using inverse planning algorithms are facilitating the treatment planning process, the irradiation dose to the normal tissues can
a critical issue. This study was performed to investigate the effect of beam numbers and their directions and local optimization
(1) dose conformity and homogeneity to the planning target volume (PTV) and (2) dose to the organ at risks (OARs). Methods:
Four upper esophageal cancer cases were randomly selected for this treatment planning study. Eight IMRT plans were
for each case with the same dose-volume constraints but with different beam numbers and arrangements. Local optimization
using regular structures drawn automatically around the PTV with margins from 0.5-1.5 cm was performed. IMRT plans were
evaluated with respect to isodose distributions, dose-volume histograms (DVHs) parameters, homogeneity index (HI), and con-
formity index (CI). The statistical comparison between the types of plans was done using the One Way ANOVA test. Results:
results showed that IMRT using three or five beams was not sufficient to obtain good dose optimization. The seven field plans
showed the best coverage for the PTV with tolerable doses for the OARs, and the beam orientation was very critical. Increasing
beams (Bs) number from 7 to 13 did not show significant differences in the PTV coverage, while the mean lung dose was in-
creased. The PTV coverage were 95.1, 95.1, 98.1, 97.3, 97.3, 97.3, 97.0, and 97.0% for 3Bs, 5Bs, 7Bs, 9Bs, 13Bs, 7Bs(30), 7Bs(60)
(beam angles were changed from 0o to 30o and 60o), and 7Bs(R) (seven IMRT plans with ring), respectively. The mean heart dose
did not exceed 0.36 Gy with p < 0.05. For lung doses, the best plan was the one with 9Bs which reduced lung volume doses V20Gy
(%) and V30Gy (%), and reduced mean lung dose from 5.4 to 4.5 Gy with p < 0.05 for 7Bs(R) plans. IMRT improved the homoge-
neity indices (p > 0.05), yet conformity was better with 9Bs and 7Bs(R) IMRT plans with p < 0.05. Conclusion: Seven equispaced
coplanar intensity-modulated beams with an addition of a ring structure can produce desirable dose distributions to the PTV.
Moreover, dose-volume of exposed normal lung can be reduced with 9Bs and 7Bs(R) IMRT plans.
Keywords: Intensity Modulated Radiotherapy; Esophageal Cancer; Local Optimization; Planning Target Volume; Organ at Risks
Introduction
Organ preservation is a common treatment goal for carcino-
ma of the cervical esophagus.1, 2, 3 Technical challenges in-
cluding rapid change in patient contour and dose-limiting
adjacent critical structures present difficulty in achieving
uniform target (tumor) coverage.4, 5 Despite these challenges,
radiotherapy is the primary treatment modality for carcino-
ma of the cervical esophagus. Innovative technologies in
radiation delivery such as intensity-modulated radiotherapy
(IMRT) offer the potential for improved tumor coverage,
while reducing the dose delivered to the surrounding normal
tissues.6 IMRT has shown to be superior to 3-dimensional
conformal radiation therapy (3DCRT) with respect to dose
conformity in multiple sites including, but not limited to the
larynx, nasopharynx, lung, and prostate.7 Multiple planning
studies have shown IMRT superiority in the treatment of
various head and neck sites as well as lower esophageal tu-
mors.8, 9 These planning studies have used to develop tech-
niques that will produce the best dosimetric results when
applied to a group of patients with a specific tumor loca-
tion.10 Consequently, IMRT has become the standard of care
for various cancers of the head and neck.11 No consensus has
been reached as to the optimal radiation technique and tar-
get volume delineation for treating cervical esophageal can-
cer. The cervical and upper thoracic esophageal regions are
characterized by variation of body thickness, the distance of
esophagus to the body surface, and the closeness of the target
to the spinal cord, which represents a unique challenge with
respect to the tumor coverage and adjacent critical structure.
A number of additional limitations and potential concerns
regarding IMRT are relevant to cervical esophageal cancer.
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Some of these limitations are dose per fraction, organ mo-
tion, and target delineation. It is a challenge to limit the dose
to the spinal cord while keeping the dose uniformity in the
target volume in the IMRT plans. In addition, the quality of
the IMRT plan also depends greatly upon the planner’s expe-
riences, and many trials and errors are required to match the
constraints. The ideal number of beams in an IMRT plan has
not been decided. Generally, a larger number of beams
would a greater flexibility to achieve a desired dose distribu-
tion. However, the more the number of beams used, the
more the effort is required for planning, quality assurance,
dosimetric verification, and treatment. Practically, it is de-
sirable to reduce the number of beams to as few as possible
without compromising the quality of the treatment.12
A number of studies have assessed whether IMRT is suitable
or effective for treating esophageal cancer, partly because of
the concern that IMRT may increase the radiation at low
doses to large volumes of normal lung tissue, which could be
detrimental to radiosensitive structures. Only few reports
have been published so far on the use of IMRT for esophage-
al cancer.9, 13 In two earlier studies,9, 109 beams (9Bs) IMRT
plans were equivalent in comparison with 3DCRT plans re-
garding planning target volume (PTV), dose homogeneity
and mean lung dose (MLD). However, the 4Bs IMRT plans
with the same beam orientation as the 3DCRT plans in-
creased the PTV dose homogeneity and reduced the mean
lung dose. A more recent report from Wu et al.13 found that
IMRT could be an effective tool to reduce volume of lung
irradiated above 25 Gy for mid-thoracic esophageal cancers.
Apparently, more extensive studies are needed to explore the
potential gains of IMRT with respect to dosimetric im-
provements before embarking on a clinical trial.
In the present work, a pilot study was carried out investigat-
ing the feasibility of using different IMRT plans for cases of
upper esophageal cancer, which typically involves irradia-
tion of normal lung tissue, spinal cord, and heart. We deter-
mined whether the best IMRT plan could reduce dose deliv-
ered to the normal lung and improve the target conformity.
Eight types of IMRT beam arrangements were made to assess
the optimal beam angles. Furthermore, authors intend to
establish IMRT treatment strategies for esophagus cancers,
and the results from this study could be useful for designing
future clinical trials.
Methods and Materials
In the present study, four upper esophageal cancer cases
were randomly selected. All of the patients had tumors in-
volving the upper and cervical esophagus. Through treat-
ment simulation session, computed tomography (CT) images
of the entire thorax were obtained using 3 mm slice spacing,
including the entire lung, spinal cord, and heart. Images
were obtained with the patients in the supine position. Pa-
tients were immobilized using with thermoplastic sheets
thermoplastic material.
The planning target volume (PTV) and organs at risk (OARs)
were delineated by a radiation oncologist on the CT slices
using contouring option in the XiO (version 4.7) treatment
planning system (TPS). The aperture based inverse planning
(or direct aperture inverse planning “DAO”) with standard
superposition algorithm was used for dose calculations. For
each patient, two different treatment volumes are defined:
clinical tumor volume (CTV) esophagus (gross tumor volume
(GTV) + margin). The margins are expanded based on the
institutional protocol for IMRT, i.e., 1 cm along the trans-
verse direction, 1 cm along the cranial caudal direction, 1 cm
anteriorly, and 0.5 cm posteriorly.
The PTV is given by the sum of CTV and margin. The mar-
gin was 4 cm proximal/distal and 1 cm radial. Eight treat-
ment plans with different beams number (Bs): 3Bs, 5Bs, 7Bs,
9Bs, 13Bs, 7Bs(30), 7Bs(60) and 7Bs(R),were generated for
each case. The effect of beam directions and local optimiza-
tion were studied with the 7Bs plans, and the beam angles
were changed from 0o to 30o and 60o, as well as, three rings
were drawn around the PTV with margins 0.5, 1, and 1.5 cm,
respectively, as automatic margins from the PTV [7Bs,
7Bs(30o), 7Bs(60o) and 7Bs(R)]. Table 1 and Figure 1 summa-
rize the number of beams and gantry angles for each plan
category. The target dose was 50.4 Gy delivered in 28 frac-
tions. The IMRT plans were generated using equispaced
beams (6 MV photon energy from Elekta Precise linear ac-
celerator).
The treatment planning parameters used to ensure coverage
of the PTV are presented in Table 2 to calculate the con-
formity index (CI). A structure called ‘normal tissue’ was
created to include all of the tissues enclosed by the external
contour (patient skin) minus the expanded PTV. The plan-
ning objectives for this structure were generally prioritized
in the following order: PTV, lung, spinal cord, heart, and
rings. The full inverse planning process of the IMRT plans
for the 7Bs was carried out 25 times, during which the prior-
ity, ranking order and treatment planning dose constraints
for each organ were adjusted to obtain plans with results
congruent with the planning goals. The treatment-planning
software uses a superposition based inverse planning algo-
rithm to generate optimal beam modulation satisfying the
physicist specified dose objectives and constraints. The goal
of optimization was to minimize the overall cost of objective
function (i.e., the function of the difference between the
desired and calculated doses for the target and all specified
critical organs). After the inverse planning, the leaf motion
required for the accelerator is generated for each IMRT plan
by using the sliding-window technique.14The final dose dis-
tribution in each plan was normalized to 95% coverage of
the PTV receiving the prescribed dose (50.4 Gy in 28
fractions).
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FIG. 1: IMRT isodose distributions in 3Bs, 5Bs, 7Bs, 9Bs, 13Bs, 7Bs(30), 7Bs(60) and 7Bs(R) plans in one of upper esophageal cancer. Red, green
and dark blue lines represent 110, 100, and 95% isodose distributions, respectively.
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FIG. 2: IMRT Dose volume histogram (DVH) in 3Bs, 5Bs, 7Bs, 9Bs, 13Bs, 7Bs(30), 7Bs(60) and 7Bs(R), plans in one case of upper esophageal
cancer. PVT (red curve), spinal cord (yellow curve), left lung (green curve), right lung (violet curve), heart (blue curve) and total volume (white
curve).
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TABLE 1: Summarizes the number of beams and gantry angles for each plan category.
Number of beams Gantry angles
3Bs 0o , 120o , 240o
5Bs 0o , 72o , 144o , 216o , 288o
7Bs 0o , 52o , 103o , 154o , 206o, 257o , 308o
9Bs 0o , 40o , 80o , 120o , 160o, 200o , 240o , 280o , 320o
13Bs 0o , 28o , 55o , 83o , 111o, 139o , 167o , 195o , 223o, 251o , 279o , 307o , 335o
7Bs(30) 30o , 82o , 134o , 186o , 238o , 290o , 342o
7Bs(60) 60o , 112o , 164o , 216o , 268o , 320o ,372o
7Bs(R) 0o , 52o , 103o , 154o , 206o, 257o , 308o
TABLE 2: IMRT dose constraints to upper esophageal cancer.
Structure Type Rank Objective Dose (Gy) Volume (%) Weight Power
PTV Target 1 Maximum
Minimum
53
51
0
100
300
300
2.8
2.6
Spinal cord OAR 2 Maximum 35 0 100 2.3
Heart OAR 3 Dose volume 38 25 100 2.0
Right lung OAR 4 Dose volume
Dose volume
Dose volume
35
8
6
5
15
30
100
100
100
2.0
2.0
2.0
Left lung OAR 5 Dose volume
Dose volume
Dose volume
35
8
6
5
15
30
100
100
100
2.0
2.0
2.0
R1 OAR 6 Maximum 50 0 100 2.0
R2 OAR 7 Maximum 41 0 100 2.0
R3 OAR 8 Maximum 35 0 100 2.0
The plans are evaluated and compared to each other accord-
ing to the following values:
 Isodose distribution
 Dose volume histogram (DVH)
 Homogeneity index (HI) of PTV
HI = (D2% - D98%)/D50%, where D2%, D98% and D50%
correspond to the dose delivered to 2, 98 and 50%
of the PTV, respectively. HI greater than 0 indi-
cates that there is a high dose difference inside the
PTV, thus, a greater degree of dose heterogeneity
in the PTV. HI of zero represents the ideal plan.
 Conformity index (CI) of PTV
CI = (V98%/PTV98%), where V98% is the volume en-
closed by the 98% of prescribed dose. Ideal CI val-
ue is 1. CI greater than 1 indicates that the volume
of 98% isodose line is greater than the PTV98% and
so greater health tissue irradiation.
 The PTV95%
 Lung Dose
 Maximum dose to spinal cord
 Mean heart dose
 Number of monitor units (MUs), number of seg-
ments, and total fraction
Results and Discussion
The present study addressed whether different IMRT tech-
niques for esophageal cancer can be used to achieve higher
PTV coverage and reduce dose to the OAR, especially the
volume of lung irradiated at low doses of 5 to 30 Gy. This
goal was achieved with all types of IMRT plans reducing
V30 Gy(%) and MLD.
PTV isodose distributions
In Figure 1, the isodose levels of 50.4 Gy are shown and the
isodose lines are displayed on an absolute dose scale. The
isodose distributions on axial images for different IMRT
plans at the isocenter of PTV for one of the four cases were
obtained. Treatment plans were produced using equispaced
non-opposed coplanar beams starting with a direct anterior
beam, and the adding ring structure provided the optimal
IMRT dose distribution. The effect of the ring on the high
dose outside the PTV was studied for the seven-field plans.
By looking at the isodose lines, the plans with three and five
beams (i.e., 3Bs and 5Bs) showed larger high-dose regions
outside the PTV as well as more normal tissues irradiation.
Some areas near the skin received high dose. The results
showed that increasing number of beams lead to decrease in
high dose regions outside the PTV and increase of the con-
formity of the prescribed dose to the PTV. Also, the use of
ring for dose optimization in 7Bs plan increased the con-
formity compared to the 9 and 13 Bs plans.
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DVH
The DVH has become a critical tool to evaluate complex 3D
absorbed dose distributions. Figure 2 shows the DVH for
different IMRT plans for the PTV and OARs for one case of
upper esophageal cancer. The mean dose to the PTV for the
four cases of upper esophageal cancer and the standard devi-
ation (SD) are listed in Table 3.Three beams plan is presented
to show the influence of the number of intensity modulated
beams. For 7Bs and 7Bs(R), the mean doses to the PTV were
98.1 and 97.1%, respectively. The DVHs were similar to
other IMRT plans, and the indices did not show any obvious
difference as the beam number increased to nine and thir-
teen. The beam direction for 7Bs plans did not improve the
PTV coverage.
HI of PTV
HI of mean PTV were 0.14 ± 0.01 and 0.14 ± 0.03 for 7Bs and
7Bs(R), respectively, with p > 0.05 which represented the
best homogenous plans (Table 3).Dose homogeneity HI of
3Bs and 5Bs were inferior with slight differences between
other plans. Figure 3 shows the relation between the number
of beams and HI for different IMRT plans in the PTV for the
cases of the upper esophageal cancer.
CI of PTV
The CI results showed that three and five equispaced copla-
nar intensity modulated beams (3Bs and 5Bs) did not meet
the requirement of dose conformity, and this may have been
due to the fact that the beams number and their directions
were not sufficient for dose optimization. The conformity
was improved as the number of intensity modulated beams
increased, but the improvement was marginal when the
number of beams was above five. As expected, high dose
conformity of the target volumes in IMRT plans was gener-
ally improved by using ring to 7Bs when compared to 9Bs
and 13Bs. Figure 4 shows the relationship between number
of beams and CI for different IMRT plans in the PTV for
cases of the upper esophageal cancer.
FIG. 3: The relationship between the number of beams and
mean HI.
FIG. 4: The relationship between the number of beams and
mean CI.
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The PTV95%
The PTV as defined by ICRU report 50 is used to select ap-
propriate beam sizes and beam arrangements. Clinically, a
plan is normally acceptable if the 95% isodose surface covers
the 100% of PTV volume. In the present work, the plan was
considered acceptable if PTV100% covered with 95% of the
prescribed dose. The targets dose coverage in all plans was
more than 95% except in 3Bs and 5Bs plans. It was possible
to reduce the number of intensity modulated beams (IMBs)
required to produce this benefit from 13Bs to 7Bs beams
without the loss of target coverage or dose homogeneity. It
has been shown that the optimization by reducing the num-
ber of IMBs from 13Bs to 7Bs had no adverse effect on the
PTV coverage (Table 3). Statistically, significant differences
in mean PTV dose are noted between the different tech-
niques. Figure 5 shows the relationship between number of
beams and PTV95% coverage for different IMRT plans of
mean PTV of cases of the upper esophageal cancer.
FIG. 5: The relationship between the number of beams and mean
PTV95%.
OARs "dose optimization"
Lung doses
The effects of beam numbers and rings on dose optimization
for lung were studied. The nine non-opposed equispaced
coplanar intensity modulated beams presented the best
treatment plan. Among four cases of the upper esophageal
cancer, the mean V5Gy (%) for the 9Bs was 21.93% with p >
0.05. The comparison for all plans with mean V5Gy (%) and its
significant values are presented in Table 3. Figure 6 shows
the relationship between the number of beams and V5Gy (%)
for the different IMRT plans. As expected, IMRT plan with
more beams (13Bs) had a greater potential for dose sculpting
than those with fewer beams (9Bs). However, because beams
have to enter patient through more directions, the volume of
normal tissue exposed to low doses is increased. This is
agreed with the previous study by Chandra et al.16 The vol-
ume of normal tissue exposed to low doses is also affected by
leakage of the dynamic multi-leaf collimator.
FIG. 6: The relationship between the number of beams and mean
V5Gy (%).
For V10Gy (%), the results showed that nine beams (9Bs) plan
was also sufficient to give the lowest doses for lung than
other plans with p > 0.05. The comparison for all plans with
mean V10Gy (%) and its significant value are presented in Ta-
ble 3. Figure 7 shows the relationship between the number
of beams and mean of V10Gy (%) for different IMRT plans in
the total lungs for the cases of the upper esophageal cancer.
FIG. 7: The relationship between the number of beams and mean
V10Gy(%).
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V20Gy (%) was reduced in the 9Bs IMRT plan among the four
cases. The mean V20Gy (%) for the 9Bs and 13Bs IMRT plans
was 7.21 and 9.23%, respectively, with p < 0.05, which rep-
resented statistical significance. The comparison among all
plans for mean V20Gy (%) and significant values are presented
in Table 3. Figure 8 shows the relationship between the
number of beams and mean of V20Gy (%) for different IMRT
plans in the total lungs for the cases of the upper esophageal
cancer.
FIG. 8: The relationship between the number of beams and mean
V20Gy (%).
V30Gy (%) was reduced in the 9Bs IMRT plan than 13Bs
among four cases. The mean V30Gy (%) for the 9Bs and 13Bs
IMRT plans was 2.45 and 3.32%, respectively, with p < 0.05,
which represented statistical significance. The comparison
among all plans for mean V30Gy (%) and significant values are
presented in Table 3. Figure 9 shows the relationship be-
tween the number of beams and mean of V30Gy (%) for dif-
ferent IMRT plans in the total lungs for the cases of the up-
per esophageal cancer.
FIG. 9: The relationship between number of beams and mean
V30Gy (%).
Figure 10 shows the relationship between the number of
beams and the MLD for different IMRT plans in the total
lungs for four cases. The obtained results were in agreement
with the previous work of Chandra et al.15but not in agree-
ment with that of the results obtained by Nutting et al.9,15
since they found that no benefit of 9Bs over the 3DCRT.
Such discrepancy may come from variation in the inverse
planning algorithms, treatment planning procedures, and
patient selection.
FIG. 10: The relationship between the number of beams and MLD.
The results showed that 9Bs IMRT plans significantly re-
duced V5Gy (%),V10Gy (%), V20Gy (%), V30Gy (%), and MLD for
the lung (Table 3). The degree of reduction on irradiated
lung volume varied from one patient to another patient. For
lung dose optimization, the 9Bs plan provided the best dosi-
metric results.
Dose to spinal cord
The dosimetric effects of different IMRT plans on the spinal
cord are explored. The results showed that all of the plans
had a maximum spinal cord dose of about 47 ± 0.4 Gy except
for 5Bs IMRT plan where the maximum dose to spinal cord
was 49 Gy with p < 0.05, which was a statistically significant
between the different IMRT plans on evaluation of the as-
signed endpoints for this structure. The comparison for all
plans with maximum dose to spinal cord and its significant
values are presented in Table 3. All doses were obtained at
0.2% of spinal cord volume. For cervical and upper esopha-
geal, the beam number and orientation have big influence on
maximum dose of spinal cord. Because of the small volume
of spinal cord for each CT slice in comparison with the target
volume, spinal cord dose optimization did not affect the PTV
optimization, and this can be achieved if the distance be-
tween the spinal cord and the PTV is more than 0.5 cm as in
the patient cases of this study. Figure 11 shows the relation-
ship between the number of beams and maximum dose to
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spinal cord for different IMRT plans for the cases of the up-
per esophageal cancer.
FIG. 11: The relationship between the number of beams and mean
spinal cord dose.
Mean heart dose
The dosimetric effects of different IMRT plans on the mean
heart dose were investigated. The results showed p< 0.05
which indicated a statistically significant between different
IMRT plans on evaluation of the assigned endpoints for this
structure. For all IMRT plans, the mean heart dose did not
exceed 0.36 Gy because a small heart volume is involved in
cervical esophagus region. The comparison for all plans with
mean heart dose and significant values are presented in Table
3. Figure 12 shows the relationship between number of
beams and mean heart dose for different IMRT plans of the
cases of the upper esophageal cancer.
FIG. 12: The relationship between the number of beams and mean
heart dose.
Number of MUs and segments
The main drawbacks of IMRT despite its efficiency in dose
conformity to tumor are increased treatment delivery time
and MUs. The increased treatment time will increase the
patients’ discomfort. Also, the increased MUs may lead to
relatively larger low-dose volume of OARs and normal tis-
sues, and this may lead to side effects such as radiation
pneumonitis as well as inducing secondary cancer.
In the present work, the seven IMRT plans with ring
[7Bs(R)] showed good homogeneity and conformity, and the
treatment time was comparable among other plans. De-
creasing the number of segments leads to reduction in the
treatment time, which made the treatment course simpler
and efficient. The reduced treatment time may come at the
cost of delivering small doses of radiation to a larger volume
of healthy tissue.
It can shorten overall treatment time, which was preferable
for treating tumors with rapid repopulation. One must con-
sider the radiobiological consequences of different fraction
sizes for the gross disease, regions of microscopic spread, and
electively treated lymph nodes. The number of segments
decreased by using 7Bs(R) IMRT plans can decrease in the
number of MUs, thus shorting the treatment time. Table 4
shows the beam arrangement of IMRT plans for four cases
with cervical and upper thoracic esophageal cancer, number
of segments, number of MUs, total fraction and treatment
time per fraction.
Dose calculation accuracy
The radiotherapy treatment for esophageal cancer is chal-
lenging by several ways: firstly, the large tumor volume and
long tumor extension may lead to delivery of high doses to
different OARs; and secondly, the tissue heterogeneity de-
mands more accurate dose calculation algorithm to computer
dose in treatment plans. The accurate dose estimations in the
presence of large tumor tissue heterogeneity are typically
performed by using superposition algorithm. The superposi-
tion algorithm takes into account lateral scattering and ap-
plies tissue heterogeneity corrections.17, 18, 19 Moreover, the
choice of the treatment planning systems is very important
in radiotherapy dose calculation, especially in the presence
of treatment planning complexity such as irregular shaped
tumors and tumor heterogeneities.20, 21
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TABLE 4: Different plans parameters for cervical and upper thoracic esophageal cancer cases.
Number of
beams
Number of
segments
Number of MUs
per fraction
Total
fraction
Total MUs Treatment Time
per fraction
3Bs 41 464.37 28 13002.26 4.50
5Bs 64 463.33 28 12973.36 6.50
7Bs 93 517.00 28 14475.95 8.72
9Bs 126 649.74 28 18192.62 11.16
13Bs 191 650.79 28 18222.15 15.16
7Bs(30) 103 616.79 28 17270.07 9.05
7Bs(60) 98 498.38 28 13954.53 8.66
7Bs(R) 87 463.86 28 12988.12 8.54
Conclusion
The preliminary findings from this study showed that if the
planning objectives are not set aggressively or appropriately
considering completing goals, the treatment planning system
will not honor various dose-volume constraints by default.
In general, for XiO TPS version 4.7, the dose prescription
should be more restricted than the desired dose prescribed to
the PTV and normal tissue, i.e., if the PTV desired dose is
50.4 Gy, the minimum dose should be at least 51 Gy in dose
optimization window of TPS. For the OARs, if the desired
maximum dose to the spinal cord is 45 Gy, the maximum
dose prescription in optimization window should be less
than or equal to 35 Gy. For dose conformity, the local opti-
mization using rings are very important. Dose-volume of
exposed normal lung can be reduced with 9Bs and 7Bs(R)
IMRT plans, although the best conformity is achieved by
7Bs(R) IMRT plan.
Acknowledgement
The authors would like to thank Dr. Hassan S.A. Abou
Elenein, Consultant of Medical Physics, Radiotherapy De-
partment, Children’s Cancer Hospital, Giza, Egypt, for his
kind help to bring this work.
Conflict of interest
The authors declare that they have no conflicts of interest.
The authors alone are responsible for the content and writ-
ing of the paper.
References
1. Burmeister BH, Dickie G, Smithers BM, Hodge R,
Morton K. Thirty-four patients with carcinoma of
the cervical esophagus treated with chemoradiation
therapy. Arch Otolaryngol Head Neck Surg 2000;
126:205-8.
2. Huang SH, Lockwood G, Brierley J, et al. Effect of
concurrent high-dose cisplatin chemotherapy and
conformal radiotherapy on cervical esophageal
cancer survival. Int J Radiat Oncol Biol Phys 2008;
71:735-40.
3. Yamada K, Murakami M, Okamoto Y, et al. Treat-
ment results of radiotherapy for carcinoma of the
cervical esophagus. Acta Oncol 2006; 45:1120-5.
4. Tai P, Van Dyk J, Yu E, et al. Variability of target
volume delineation in cervical esophageal cancer.
Int J Radiat Oncol Biol Phys 1998; 42:277-88.
5. Tai P, Van Dyk J, Yu E, et al. Radiation treatment
for cervical esophagus: patterns of practice study in
Canada, 1996. Int J Radiat Oncol Biol Phys 2000;
47:703-12.
6. Wu Q, Manning M, Schmidt-Ullrich R, Mohan R.
The potential for sparing of parotids and escalation
of biologically effective dose with intensi-
ty-modulated radiation treatments of head and
neck cancers: a treatment design study. Int J Radiat
Oncol Biol Phys 2000; 46:195-205.
7. Wu VW, Kwong DL, Sham JS. Target dose con-
formity in 3-dimensional conformal radiotherapy
and intensity modulated radiotherapy. Radiother
Oncol 2004; 71:201-6.
8. Hsiung CY, Yorke ED, Chui CS, et al. Intensi-
ty-modulated radiotherapy versus conventional
three-dimensional conformal radiotherapy for
boost or salvage treatment of nasopharyngeal car-
cinoma. Int J Radiat Oncol Biol Phys 2002;
53:638-47.
9. Nutting CM, Bedford JL, Cosgrove VP, et al. A
comparison of conformal and intensity-modulated
techniques for oesophageal radiotherapy. Radiother
Oncol 2001; 61:157-63.
10. Nutting C, Dearnaley DP, Webb S. Intensity mod-
ulated radiation therapy: a clinical review. Br J Ra-
diol 2000; 73:459-69.
11. Lee N, Xia P, Fischbein NJ, et al. Intensi-
ty-modulated radiation therapy for head-and-neck
cancer: the UCSF experience focusing on target
volume delineation. Int J Radiat Oncol Biol Phys
2003; 57:49-60.
12. Fu WH, Wang LH, Zhou ZM, et al. Comparison of
conformal and intensity-modulated techniques for
simultaneous integrated boost radiotherapy of up-
per esophageal carcinoma. World J Gastroenterol
2004; 10:1098-102.
12 Amin et al.: IMRT techniques for esophageal cancer International Journal of Cancer Therapy and Oncology
www.ijcto.org
©Amin et al. ISSN 2330-4049
13. Wu V, Sham J, Kwong D. Inverse planning in
three-dimensional conformal and intensi-
ty-modulated radiotherapy of mid-thoracic esoph-
ageal cancer. Br J Radiol 2004; 77:568-72.
14. Spirou SV, Chui CS. Generation of arbitrary inten-
sity profiles by dynamic jaws or multileaf collima-
tors. Med Phys 1994; 21:1031-41.
15. Nutting CM, Bedford JL, Cosgrove VP, et al. Inten-
sity-modulated radiotherapy reduces lung irradia-
tion in patients with carcinoma of the oesophagus.
Front Radiat Ther Oncol 2002; 37:128-31.
16. Chandra A, Guerrero TM, Liu HH, et al. Feasibility
of using intensity-modulated radiotherapy to im-
prove lung sparing in treatment planning for distal
esophageal cancer. Radiother Oncol 2005;
77:247-53.
17. Amankwaa-Frempong E, Vernimmen F, Blay S,
Ezhilalan R. Irradiation of lung and esophagus tu-
mors: A comparison of dose distributions calculated
by anisotropic analytical algorithm and pencil
beam convolution algorithm, a retrospective dosi-
metric study. Int J Cancer Ther Oncol 2014;
2:020210.
18. Chaikh A, Giraud J, Balosso J. A method to quanti-
fy and assess the dosimetric and clinical impact re-
sulting from the heterogeneity correction in radio-
therapy for lung cancer. Int J Cancer Ther Oncol
2014; 2:020110.
19. Rana SB. Dose prediction accuracy of anisotropic
analytical algorithm and pencil beam convolution
algorithm beyond high density heterogeneity in-
terface. South Asian J Cancer 2013; 2:26-30.
20. Ojala J. The accuracy of the Acuros XB algorithm
in external beam radiotherapy: a comprehensive
review. Int J Cancer Ther Oncol 2014; 2:020417.
21. Rana S, Rogers K. Radiobiological evaluation of
dose calculation algorithms in Rapid Arc planning
of esophageal cancer treatment plans. J Solid Tu-
mors 2013; 3:44-52.
